Immutep Announces Successful Meeting with FDA on Phase III Design in Non-Small Cell Lung Cancer

Sunday, July 21, 2024 1 min read

Key Takeaway: Immutep Announces Successful Meeting with FDA on Phase III Design in Non-Small Cell Lung Cancer

Full Press Release Details

Immutep Announces Successful Meeting with FDA on Phase III Design in Non-Small Cell Lung Cancer.